{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:59:15Z","timestamp":1789498755593,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Interdisciplinary Centre for Clinical Research (IZKF) of the University of W\u00fcrzburg","award":["A-302"],"award-info":[{"award-number":["A-302"]}]},{"DOI":"10.13039\/501100003493","name":"Gemeinn\u00fctzige Hertie Stiftung","doi-asserted-by":"crossref","award":["P1150084"],"award-info":[{"award-number":["P1150084"]}],"id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ymthe.2017.04.021","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T05:17:50Z","timestamp":1494652670000},"page":"1889-1899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Janos","family":"Groh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Berve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Pt B","key":"10.1016\/j.ymthe.2017.04.021_bib1","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL Neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10 Pt B","key":"10.1016\/j.ymthe.2017.04.021_bib2","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.04.021_bib3","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","article-title":"NCL disease mechanisms","volume":"1832","author":"Palmer","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"10 Pt B","key":"10.1016\/j.ymthe.2017.04.021_bib4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.04.021_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/brain\/awt020","article-title":"Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"136","author":"Groh","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.04.021_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/glia.22962","article-title":"Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease","volume":"64","author":"Groh","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2017.04.021_bib7","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","article-title":"Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.04.021_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1469-8749.1974.tb04183.x","article-title":"Infantile type of so-called neuronal ceroid-lipofuscinosis","volume":"16","author":"Santavuori","year":"1974","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.04.021_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2017.04.021_bib11","first-page":"213","article-title":"A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)","volume":"12","author":"Chun","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymthe.2017.04.021_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cei.12195","article-title":"Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies","volume":"175","author":"Melzer","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2051-5960-2-54","article-title":"Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography","volume":"2","author":"Groh","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2017.04.021_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2006.09.005","article-title":"IgG entry and deposition are components of the neuroimmune response in Batten disease","volume":"25","author":"Lim","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.04.021_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J.\u00a0Neuroimmunol"},{"key":"10.1016\/j.ymthe.2017.04.021_bib16","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","article-title":"An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis","volume":"34","author":"Macauley","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.04.021_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases - clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.04.021_bib18","first-page":"807","article-title":"Adrenoleukodystrophies","volume":"Volume 2","author":"Moser","year":"2004"},{"key":"10.1016\/j.ymthe.2017.04.021_bib19","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1515\/hsz-2013-0219","article-title":"Molecular triggers of neuroinflammation in mouse models of demyelinating diseases","volume":"394","author":"Barrette","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.04.021_bib20","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2017.04.021_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40265-014-0212-x","article-title":"Teriflunomide and its mechanism of action in multiple sclerosis","volume":"74","author":"Bar-Or","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2017.04.021_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12031-013-9979-6","article-title":"FTY720 (fingolimod) attenuates beta-amyloid peptide (A\u03b242)-induced impairment of spatial learning and memory in rats","volume":"50","author":"Asle-Rousta","year":"2013","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2017.04.021_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2013.06.016","article-title":"Neurorestorative effect of FTY720 in a rat model of Alzheimer\u2019s disease: comparison with memantine","volume":"252","author":"Hemmati","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymthe.2017.04.021_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","article-title":"Fingolimod provides long-term protection in rodent models of cerebral ischemia","volume":"69","author":"Wei","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib25","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/STROKEAHA.113.002880","article-title":"FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection","volume":"44","author":"Kraft","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ymthe.2017.04.021_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1567202613666160823152446","article-title":"Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency","volume":"13","author":"Schuhmann","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.ymthe.2017.04.021_bib27","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.04.021_bib28","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.04.021_bib29","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1167\/iovs.12-9662","article-title":"The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL\/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes","volume":"53","author":"Mattapallil","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.04.021_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/intimm\/dxn023","article-title":"Modulation of T\u00a0cell homeostasis and alloreactivity under continuous FTY720 exposure","volume":"20","author":"Metzler","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib31","first-page":"89","article-title":"Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis","volume":"256","author":"Merrill","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J.\u00a0Basic Clin. Pharm."},{"key":"10.1016\/j.ymthe.2017.04.021_bib33","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1523\/JNEUROSCI.1921-06.2006","article-title":"Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes","volume":"26","author":"Ip","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.04.021_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2353\/ajpath.2010.090722","article-title":"Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice","volume":"176","author":"Kroner","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2017.04.021_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T22:25:13Z","timestamp":1535840713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1525001617302022"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}